Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells

Kuan Der Lee, Mei Yu Pai, Chia Chen Hsu, Chih Cheng Chen, Yao Li Chen, Pei Yi Chu, Chia Huei Lee, Li Tzong Chen, Jang Yang Chang, Tim H.M. Huang, Shu Huei Hsiao, Yu Wei Leu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Casp8AP2 contains a FLASH functional domain and is critical for the formation of death complex and the relay of death signal into the cells. Genetic defects in Casp8AP2 are associated with several diseases. A CpG island within the Casp8AP2 promoter is differentially regulated during somatic stem cell differentiation, and aberrant DNA methylation within the Casp8AP2 promoter has been reported in cancers. We hypothesized that abnormal DNA methylation of Casp8AP2 promoter might contribute to prolonged cellular survival or drug resistance in cancer. The epigenetic state within theCasp8AP2 promoter was then determined in different cancer cell lines and patient samples by methylation-specific PCR. Targeted Casp8AP2 methylation within normal and tumor cells was performed to see whether methylation promoted drug resistance. We found differential Casp8AP2 methylation among the normal and tumoral samples. Global demethylation in a platinum drug-resistant human gastric cancer cell line reversed Casp8AP2 methylation and diminished drug resistance. Targeted methylation of the Casp8AP2 promoter in somatic stem cells and cancer cells increased their resistance to drugs including platinum drugs. These data demonstrate that methylation within the Casp8AP2 promoter correlates with the development of drug resistance and might serve as a biomarker and treatment target for drug resistance in cancer cells.

Original languageEnglish
Pages (from-to)578-585
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume422
Issue number4
DOIs
Publication statusPublished - Jun 15 2012
Externally publishedYes

Fingerprint

Methylation
Stem cells
Mesenchymal Stromal Cells
Drug Resistance
Cells
Pharmaceutical Preparations
Neoplasms
Adult Stem Cells
DNA Methylation
Platinum
Cell Line
CpG Islands
Epigenomics
Biomarkers
Stomach Neoplasms
Cell Differentiation
Tumors
Polymerase Chain Reaction
Survival
Defects

Keywords

  • Cell death
  • Chromatin immunoprecipitation
  • DNA methylation
  • Epigenetic
  • Histone modification

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells. / Lee, Kuan Der; Pai, Mei Yu; Hsu, Chia Chen; Chen, Chih Cheng; Chen, Yao Li; Chu, Pei Yi; Lee, Chia Huei; Chen, Li Tzong; Chang, Jang Yang; Huang, Tim H.M.; Hsiao, Shu Huei; Leu, Yu Wei.

In: Biochemical and Biophysical Research Communications, Vol. 422, No. 4, 15.06.2012, p. 578-585.

Research output: Contribution to journalArticle

Lee, KD, Pai, MY, Hsu, CC, Chen, CC, Chen, YL, Chu, PY, Lee, CH, Chen, LT, Chang, JY, Huang, THM, Hsiao, SH & Leu, YW 2012, 'Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells', Biochemical and Biophysical Research Communications, vol. 422, no. 4, pp. 578-585. https://doi.org/10.1016/j.bbrc.2012.05.029
Lee, Kuan Der ; Pai, Mei Yu ; Hsu, Chia Chen ; Chen, Chih Cheng ; Chen, Yao Li ; Chu, Pei Yi ; Lee, Chia Huei ; Chen, Li Tzong ; Chang, Jang Yang ; Huang, Tim H.M. ; Hsiao, Shu Huei ; Leu, Yu Wei. / Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells. In: Biochemical and Biophysical Research Communications. 2012 ; Vol. 422, No. 4. pp. 578-585.
@article{829c0b7d838f4e7084c63357bee0f727,
title = "Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells",
abstract = "Casp8AP2 contains a FLASH functional domain and is critical for the formation of death complex and the relay of death signal into the cells. Genetic defects in Casp8AP2 are associated with several diseases. A CpG island within the Casp8AP2 promoter is differentially regulated during somatic stem cell differentiation, and aberrant DNA methylation within the Casp8AP2 promoter has been reported in cancers. We hypothesized that abnormal DNA methylation of Casp8AP2 promoter might contribute to prolonged cellular survival or drug resistance in cancer. The epigenetic state within theCasp8AP2 promoter was then determined in different cancer cell lines and patient samples by methylation-specific PCR. Targeted Casp8AP2 methylation within normal and tumor cells was performed to see whether methylation promoted drug resistance. We found differential Casp8AP2 methylation among the normal and tumoral samples. Global demethylation in a platinum drug-resistant human gastric cancer cell line reversed Casp8AP2 methylation and diminished drug resistance. Targeted methylation of the Casp8AP2 promoter in somatic stem cells and cancer cells increased their resistance to drugs including platinum drugs. These data demonstrate that methylation within the Casp8AP2 promoter correlates with the development of drug resistance and might serve as a biomarker and treatment target for drug resistance in cancer cells.",
keywords = "Cell death, Chromatin immunoprecipitation, DNA methylation, Epigenetic, Histone modification",
author = "Lee, {Kuan Der} and Pai, {Mei Yu} and Hsu, {Chia Chen} and Chen, {Chih Cheng} and Chen, {Yao Li} and Chu, {Pei Yi} and Lee, {Chia Huei} and Chen, {Li Tzong} and Chang, {Jang Yang} and Huang, {Tim H.M.} and Hsiao, {Shu Huei} and Leu, {Yu Wei}",
year = "2012",
month = "6",
day = "15",
doi = "10.1016/j.bbrc.2012.05.029",
language = "English",
volume = "422",
pages = "578--585",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
number = "4",

}

TY - JOUR

T1 - Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells

AU - Lee, Kuan Der

AU - Pai, Mei Yu

AU - Hsu, Chia Chen

AU - Chen, Chih Cheng

AU - Chen, Yao Li

AU - Chu, Pei Yi

AU - Lee, Chia Huei

AU - Chen, Li Tzong

AU - Chang, Jang Yang

AU - Huang, Tim H.M.

AU - Hsiao, Shu Huei

AU - Leu, Yu Wei

PY - 2012/6/15

Y1 - 2012/6/15

N2 - Casp8AP2 contains a FLASH functional domain and is critical for the formation of death complex and the relay of death signal into the cells. Genetic defects in Casp8AP2 are associated with several diseases. A CpG island within the Casp8AP2 promoter is differentially regulated during somatic stem cell differentiation, and aberrant DNA methylation within the Casp8AP2 promoter has been reported in cancers. We hypothesized that abnormal DNA methylation of Casp8AP2 promoter might contribute to prolonged cellular survival or drug resistance in cancer. The epigenetic state within theCasp8AP2 promoter was then determined in different cancer cell lines and patient samples by methylation-specific PCR. Targeted Casp8AP2 methylation within normal and tumor cells was performed to see whether methylation promoted drug resistance. We found differential Casp8AP2 methylation among the normal and tumoral samples. Global demethylation in a platinum drug-resistant human gastric cancer cell line reversed Casp8AP2 methylation and diminished drug resistance. Targeted methylation of the Casp8AP2 promoter in somatic stem cells and cancer cells increased their resistance to drugs including platinum drugs. These data demonstrate that methylation within the Casp8AP2 promoter correlates with the development of drug resistance and might serve as a biomarker and treatment target for drug resistance in cancer cells.

AB - Casp8AP2 contains a FLASH functional domain and is critical for the formation of death complex and the relay of death signal into the cells. Genetic defects in Casp8AP2 are associated with several diseases. A CpG island within the Casp8AP2 promoter is differentially regulated during somatic stem cell differentiation, and aberrant DNA methylation within the Casp8AP2 promoter has been reported in cancers. We hypothesized that abnormal DNA methylation of Casp8AP2 promoter might contribute to prolonged cellular survival or drug resistance in cancer. The epigenetic state within theCasp8AP2 promoter was then determined in different cancer cell lines and patient samples by methylation-specific PCR. Targeted Casp8AP2 methylation within normal and tumor cells was performed to see whether methylation promoted drug resistance. We found differential Casp8AP2 methylation among the normal and tumoral samples. Global demethylation in a platinum drug-resistant human gastric cancer cell line reversed Casp8AP2 methylation and diminished drug resistance. Targeted methylation of the Casp8AP2 promoter in somatic stem cells and cancer cells increased their resistance to drugs including platinum drugs. These data demonstrate that methylation within the Casp8AP2 promoter correlates with the development of drug resistance and might serve as a biomarker and treatment target for drug resistance in cancer cells.

KW - Cell death

KW - Chromatin immunoprecipitation

KW - DNA methylation

KW - Epigenetic

KW - Histone modification

UR - http://www.scopus.com/inward/record.url?scp=84862295663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862295663&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2012.05.029

DO - 10.1016/j.bbrc.2012.05.029

M3 - Article

VL - 422

SP - 578

EP - 585

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -